
Brouwinkind Pharmalab Private Limited
About Brouwinkind Pharmalab Private Limited
Data last updated:
Brouwinkind Pharmalab Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 September 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2008PTC183320. Its GSTIN is 07AADCB5703B1ZA (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Burroughs Wellcome Pharmalab Private Limited and Burroughs Wellcome Pharmalab Limited. It is led by directors Parkash Thirani and August Kumar Thirani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 12 109/2 Cc Colony Buddha Appartment, Delhi, India – 110009.
As per the financials filed for FY 2024, the company reported a revenue of ₹12,235, a growth of 20% compared to the previous year. For the same year it recorded a net loss of ₹47,188 (net margin -385.7%) and EBITDA of -₹18,038 (EBITDA margin -147.4%). Revenue has declined at a compounded annual rate (CAGR) of 79% over five years.
As per MCA filings, the company has open charges of ₹3.5 Cr on record. Court records list 7 cases involving the company, including 6 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Brouwinkind Pharmalab has undergone 2 name changes throughout its history. The company was previously known as Burroughs Wellcome Pharmalab Private Limited, and Burroughs Wellcome Pharmalab Limited. The current legal name is Brouwinkind Pharmalab Private Limited.
| Company Name | Status |
|---|---|
| Brouwinkind Pharmalab Private Limited | Current |
| Burroughs Wellcome Pharmalab Private Limited | Previous |
| Burroughs Wellcome Pharmalab Limited | Previous |
CIN history
Brouwinkind Pharmalab has one previous CIN (Corporate Identification Number): U33110DL2008PLC183320. The current CIN is U33110DL2008PTC183320, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33110DL2008PTC183320 | Current |
| U33110DL2008PLC183320 | Previous |
Contact details
Brouwinkind Pharmalab Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 12 109/2 Cc Colony Buddha Appartment, Delhi, India – 110009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Brouwinkind Pharmalab Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Brouwinkind Pharmalab Private Limited
FY 2025 filings availableBrouwinkind Pharmalab Private Limited reported revenue of ₹12,235 (up 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 20% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 79%. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹18,038 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹47,188 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -147.4% | ||||
| Net Profit Margin | -385.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brouwinkind Pharmalab Private Limited, buy the company report.
Board of directors of Brouwinkind Pharmalab Private Limited
Brouwinkind Pharmalab has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parkash Thirani | Director | 09 Jul 2009 | 17 Years 3 Months | Current |
| August Kumar Thirani | Director | 09 Jul 2009 | 17 Years 3 Months | Current |
Peer comparison
Brouwinkind Pharmalab Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Galaxystar Pharma Private Limited | ₹13,151 (FY 2022) | -93.0% | Mumbai, Maharashtra, India | |||
| Healwell Pharmaceuticals Private Limited | ₹13,094 (FY 2024) | 4.0% | Delhi, India | |||
| Drish Lifesciences Limited | ₹13,039 (FY 2024) | 7.0% | Jalandhar, Punjab, India | |||
| Nurturaa Health Tech Private Limited | ₹13,000 (FY 2025) | Hyderabad, Telangana, India | ||||
| Mediways Chemist Private Limited | ₹12,483 (FY 2025) | 438.0% | Ghaziabad, Uttar Pradesh, India | |||
| Brouwinkind Pharmalab Private Limitedthis company | ₹12,235 (FY 2024) | -₹47,188 | -385.7% | 20.0% | Delhi, India | |
| Aarti Pharmaceuticals Private Limited | ₹12,211 (FY 2025) | New Delhi, Delhi, India | ||||
| Remedy Drugs Pvt Ltd | ₹12,055 (FY 2025) | Indore, Madhya Pradesh, India | ||||
| Vios Aiming Progress Private Limited | ₹12,000 (FY 2018) | Bhopal, Madhya Pradesh, India | ||||
| Gracious Healthcare Private Limited | ₹12,000 (FY 2024) | 18.0% | Delhi, India | |||
| Ishir Pharmaceuticals Private Limited | ₹12,000 (FY 2023) | 76.0% | New Delhi, Delhi, India |
To see the full peer comparison of Brouwinkind Pharmalab Private Limited, buy the company report.
Auditor
Brouwinkind Pharmalab Private Limited is audited by R BHARGAVA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R BHARGAVA & ASSOCIATES | FY 2019 | 012788N |
Shareholding
The shareholding of Brouwinkind Pharmalab Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Brouwinkind Pharmalab Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Aug 2009 | 10173537 | Uco Bank | ₹3.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Brouwinkind Pharmalab Private Limited has 7 court cases on record: 6 filed by Brouwinkind Pharmalab, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed by the company against Innova Pharma | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against an individual | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against an individual | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against an individual | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of Brouwinkind Pharmalab Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brouwinkind Pharmalab Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Brouwinkind Pharmalab has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCB5703B1ZA | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Brouwinkind Pharmalab Private Limited, buy the company report.
Recent activity
Brouwinkind Pharmalab Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Mahesh Kumar Bhartia ceased to be Director on 01 Nov 2011.
Frequently asked questions
Brouwinkind Pharmalab is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 September 2008 (18+ years old) and is registered under CIN U33110DL2008PTC183320.
Brouwinkind Pharmalab has 2 current directors:
- Parkash Thirani - Director
- August Kumar Thirani - Director
The latest financial statements of Brouwinkind Pharmalab on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Brouwinkind Pharmalab is 07AADCB5703B1ZA, registered in Delhi.
The CIN (Corporate Identification Number) of Brouwinkind Pharmalab is U33110DL2008PTC183320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brouwinkind Pharmalab has 7 court cases on record: 6 filed by the company and 1 filed against it. Most are in the district courts.
Brouwinkind Pharmalab was incorporated on 16 September 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Brouwinkind Pharmalab by revenue are Galaxystar Pharma Private Limited, Healwell Pharmaceuticals Private Limited, Drish Lifesciences Limited, Nurturaa Health Tech Private Limited, Mediways Chemist Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Mahesh Kumar Bhartia ceased to be Director on 01 Nov 2011. Suresh Kumar Bharatia ceased to be Director on 01 Nov 2011. Vishwambhar Dayal Bhartia ceased to be Director on 01 Nov 2011. Brouwinkind Pharmalab has 5 board changes on record in total.
The registered office of Brouwinkind Pharmalab is at Flat No. 12 1092 Cc Colony Buddha Appartment, Delhi, India – 110009.
Brouwinkind Pharmalab operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

